Skip to main content

Table 1 Baseline clinical features difference between PPSC and ASOC patients

From: Differences between primary peritoneal serous carcinoma and advanced serous ovarian carcinoma: a study based on the SEER database

Clinical features

PPSC N = 708(%)

ASOC N = 7610(%)

Total N = 8318(%)

P value

Age

<  0.001

  ≤ 49

41 (5.8)

1447 (19.0)

1488 (17.9)

 

 50–69

387 (54.7)

4363 (57.3)

4750 (57.1)

 

  ≥ 70

280 (39.5)

2100 (27.6)

2380 (28.6)

 

Race

0.003

 White

600 (84.7)

6393 (84.0)

8365 (84.1)

 

 Black

31 (4.4)

560 (7.4)

693 (7.0)

 

 Others

77 (10.9)

657 (8.6)

886 (8.9)

 

Marital status

0.740

 Married

398 (56.2)

4164 (54.7)

4562 (54.8)

 

 Not married

283 (40.0)

3153 (41.4)

3436 (41.3)

 

 Unknown

27 (3.8)

293 (3.9)

391 (3.8)

 

Tumor grade

0.003

 I

18 (2.5)

179 (2.4)

197 (2.4)

 

 II

88 (12.4)

634 (8.3)

722 (8.7)

 

 III

318 (44.9)

3539 (46.5)

3857 (46.4)

 

 IV

284 (40.1)

3258 (42.8)

3542 (42.6)

 

AJCC stage

0.105

 III

466 (65.8)

5234 (68.8)

5700 (68.5)

 

 IV

242 (34.2)

2376 (31.2)

2618 (31.5)

 

Chemotherapy

0.605

 Yes

626 (88.4)

6678 (87.8)

7304 (87.8)

 

 No/Unknown

82 (11.6)

932 (12.2)

1014 (12.2)

 

Surgery

<  0.001

 Yes

649 (91.7)

7215 (94.8)

7864 (94.5)

 

 No/Unknown

59 (8.3)

395 (5.2)

454 (5.5)

 
  1. PPSC primary peritoneal serous carcinoma, ASOC advanced serous ovarian cancer, AJCC American Joint Committee on Cancer